Polyomavirus neutralizing antibodies
US10450366B2 · kind B2 · utility
5Cited by
1References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 8, 2016 |
| Grant date | Oct 22, 2019 |
| Priority date | — |
| Expiry date | Sep 8, 2036 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure is directed to anti-VP1 antibodies, antibody fragments, and their uses for the reducing the likelihood or treatment of polyoma virus infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.